LXFR LUXFER HOLDINGS PLC
Industrial Inorganic Chemicals · NYSE · SEC CIK 1096056 · Fiscal year ends 12/31
Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year
Growth
TTM revenue YoY-1.9%
TTM net income YoY-58.2%
TTM EPS YoY-58.8%
Revenue 3-yr CAGR-3.2%
Net income 3-yr CAGR-34.1%
Margins
Gross margin23.2%
Operating margin6.2%
Net margin2.0%
FCF margin6.8%
EBITDA margin8.8%
Returns
ROE3.5%
ROA2.0%
ROIC (approx.)5.5%
Asset turnover1.02x
Leverage & solvency
Liabilities / assets38.8%
Debt / equity0.17x
Current ratio1.67x
Interest coverage7.74x
Cash quality & payout
Operating cash flow / net income4.42x
Accruals ratio-7.0%
Payout ratio180.5%
Capex / revenue2.0%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $384.60M | $391.90M |
| Cost of revenue | $295.40M | $306.20M |
| Gross profit | $89.20M | $85.70M |
| R&D expense | $4.30M | $4.40M |
| SG&A expense | $49.10M | $48.10M |
| Operating income | $24.00M | $30.10M |
| Interest expense | $3.10M | $5.20M |
| Pretax income | $22.20M | $26.50M |
| Income tax | $9.10M | $8.20M |
| Net income | $7.70M | $18.40M |
| EBITDA | $33.90M | $40.20M |
| EPS (basic) | 0.29 | 0.69 |
| EPS (diluted) | 0.28 | 0.68 |
| Weighted avg. shares (diluted) | 27.25M | 27.08M |
| Balance sheet | ||
| Cash & equivalents | $8.30M | $4.10M |
| Receivables | $50.00M | $45.80M |
| Inventory | $92.40M | $83.60M |
| Current assets | $164.00M | $175.80M |
| PP&E, net | $60.20M | $62.80M |
| Goodwill | $69.60M | $67.00M |
| Intangibles | $10.90M | $11.50M |
| Total assets | $369.70M | $382.40M |
| Current liabilities | $98.20M | $93.70M |
| Short-term debt | $25.00M | $3.10M |
| Long-term debt | $14.40M | $42.00M |
| Total debt | $39.40M | $45.10M |
| Total liabilities | $143.30M | $162.90M |
| Shareholders' equity | $226.40M | $219.50M |
| Net debt | $31.10M | $41.00M |
| Shares outstanding | 26.64M | 26.74M |
| Cash flow statement | ||
| Operating cash flow | $34.00M | $51.10M |
| Capital expenditure | $7.80M | $10.30M |
| Free cash flow | $26.20M | $40.80M |
| Investing cash flow | -$5.10M | -$3.40M |
| Financing cash flow | -$25.00M | -$44.00M |
| Depreciation & amortization | $9.90M | $10.10M |
| Stock-based compensation | $3.60M | $3.50M |
| Dividends paid | $13.90M | $14.00M |
| Share buybacks | $3.10M | $2.30M |
Free plan shows the latest 2 periods; Pro shows all 11 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.